- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03398772
Effects of a Comprehensive Health Coaching Program in Advanced Chronic Obstructive Pulmonary Disease.
Effects of a Comprehensive Health Coaching Program on Lung Function, Exercise Tolerance, Symptom Distress, Quality of Life, Readmission, and Survival in Advanced Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial.
Chronic obstructive pulmonary disease due to incurable and prevalence has increased steadily, chronic respiratory disease is considered hazardous to health and quality of life of the disease. GOLD treatment guidelines (global initiative for chronic obstructive lung disease guideline) pointed out the pulmonary rehabilitation is one of the non-drug treatment in patients with severe COPD, shown to improve exercise capacity and reduce the short of breathing, improve the quality of life and reduce the anxiety associated and depression and improved survival advantages. Meanwhile, a few studies have examined effect the exercise training in severe COPD patients' symptom distress and quality of life, so as to make severe COPD patients to improve the effectiveness of the campaign to ongoing regular pulmonary rehabilitation movement, is considered an important issue.
It has been proposed that physical activity enhancement or exercise training can be effective in improving symptoms and quality of life in these patients. However, it has not been examined systematically. Therefore, the main purposes of this study are: 1.Prevalence of symptom distress; 2.The physical preferences; 3.The relationship between quality of life and physical activity; 4.Effects of Comprehensive Health coaching exercise training on improving fatigue, sleep disturbances, quality of life, readmission, and survival. In the first year of this study, a descriptive-correlational design will be used and in the second and third years of study, the experimental design and prospective longitudinal study will be undertaken. Instruments include motion sensors, physical activity scale, Physical Activity Preferences, Pittsburgh Sleep Quality of Life Index. Statistical analyses include descriptive statistics, t-test, one-way ANOVA, latent growth modeling, Logistic models, GEE, and survival analysis. Results from this study will provide important implications for improving symptom management and quality of life for sever chronic obstructive pulmonary disease patients.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Taipei, Taiwan
- Rekrytering
- Taipei Medical Hospital-Shuang Ho Hospital,Ministry of Health and Welfare
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- age ≥40 years and ≦80 years
- patients with advanced COPD are defined according to the diagnostic criteria for severe (GOLD 3) and very severe (GOLD 4)
- pulmonologist assess need pulmonary rehabilitation, but not accept any rehabilitation exercise program.
- pulmonologist assessment the patients with a stable state.
- awareness, has the ability to read, write, and communication.
- willing to communicate by phone, and can operate smart phones.
Exclusion Criteria:
- COPD AE requiring corticosteroids, antibiotics, emergency room visit or hospitalization within the past 3 month.
- diagnosed mentally or cognitive disorder, such as dementia or unable to cooperate.
- severe hip, knee disease, can not perform exercise, or with neuromuscular dysfunction, such as limb hemiplegia, no independent walking function or other deterioration due to bone and joint disease.
- combined with severe heart disease, such as AMI, severe arrhythmia or heart failure.
- current regular practice of physical activity
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Experiment
Comprehensive Health Coaching Program
|
Comprehensive Health Coaching Program: included physical activity and motivational interviewing techniques, participants were encouraged to set goals with decision-making, self-management and self-monitor their progress, and received support from researcher.
|
|
Inget ingripande: Control
Guideline-based usual care
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change from Baseline Lung function at 3 months, 6months
Tidsram: 3 months, 6months
|
Spirometry (FEVl % predicted )
|
3 months, 6months
|
|
Change from Baseline Exercise Tolerance at 3 months, 6months
Tidsram: 3 months, 6months
|
6 Minute walking test
|
3 months, 6months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change from Baseline Health-related quality of life at 3 months, 6months
Tidsram: 3 months, 6months
|
St. George's Respiratory Questionnaire
|
3 months, 6months
|
|
Change from Baseline Fatigue at 3 months, 6months
Tidsram: 3 months, 6months
|
Brief Fatigue Inventory Short Form BFI-Taiwan Form
|
3 months, 6months
|
|
Change from Baseline Psychological distress at 3 months, 6months
Tidsram: 3 months, 6months
|
Hospital Anxiety and Depression Scale
|
3 months, 6months
|
|
Change from Baseline Symptom Distress at 3 months, 6months
Tidsram: 3 months, 6months
|
Taiwanese version of the M. D. Anderson Symptom Inventory
|
3 months, 6months
|
|
Change from Baseline Quality of Sleep at 3 months, 6months
Tidsram: 3 months, 6months
|
Taiwanese version of the Pittsburgh Sleep Quality Index
|
3 months, 6months
|
|
Readmission rate Survival
Tidsram: 1 year
|
pulmonologists blinded to allocation reviewed admission summaries and information to determine as COPD related readmission or mortality
|
1 year
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- N201704032
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .